Diltiazem is used to treat high blood pressure and to control angina (chest pain). Diltiazem is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels, so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart. According to our latest study on “Diltiazem Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product type and application,” the market is projected to reach US$ 832.51 million by 2028 from US$ 369.95 million in 2021; it is expected to grow at a CAGR of 12.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Get More Information @ https://www.theinsightpartners.com/reports/diltiazem-market

Market leaders operating in the market have undertaken various organic growth strategies in the Diltiazem market. The Diltiazem market majorly consists of the players Bausch Health, Teva Pharmaceutical Industries Ltd, Mylan N.V, Athenex, Pfizer, Inc, Glenmark, Sandoz (Novartis Ag),Sun Pharmaceutical Company Ltd, Hikma Pharmaceuticals, Zydus Pharmaceuticals among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaborations.

Based on application, the diltiazem market is segmented into segmented into angina, hypertension, and others. In 2021, the hypertension segment held the largest share of the market, by application. Whereas the Angina segment is expected to grow at the fastest CAGR during the coming years. Diltiazem is used to treat high blood pressure and to control angina (chest pain). Diltiazem is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels, so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart. Thus, rising heart disease and angina is likely to boost the growth of market. For instance, Heart disease cases nearly doubled over the period from 271 million in 1990 to 523 million in 2019, and the number of heart disease deaths rose from 12.1 million to 18.6 million. In 2019, the majority of heart disease deaths were attributed to ischemic heart disease and stroke, with a steady increase from 1990.

Contact Us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876